Samsung Biologics
207940.KS
#425
Rank
โ‚น4.013 T
Marketcap
โ‚น56,384
Share price
-0.64%
Change (1 day)
21.67%
Change (1 year)

Samsung Biologics (207940.KS) - Cash on Hand

Cash on Hand as of March 2024 : โ‚น129.27 Billion

According to Samsung Biologics 's latest financial reports the company has โ‚น129.27 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Samsung Biologics - Cash on Hand chart (from 2016 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น132.33 B-36.86%
2022-12-31โ‚น209.58 B144.31%
2021-12-31โ‚น85.78 B49.57%
2020-12-31โ‚น57.35 B34.81%
2019-12-31โ‚น42.54 B-39.81%
2018-12-31โ‚น70.69 B210.04%
2017-12-31โ‚น22.80 B-66.75%
2016-12-31โ‚น68.58 B3415.24%
2015-12-31โ‚น1.95 B-64.98%
2014-12-31โ‚น5.57 B